Literature DB >> 23935158

Glutamate and migraine: from Ikeda to the 21st century.

Nabih M Ramadan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23935158     DOI： 10.1177/0333102413499646

Source DB:  PubMed          Journal:  Cephalalgia        ISSN： 0333-1024            Impact factor:   6.292


× No keyword cloud information.
  6 in total

Review 1.  Animal models of chronic migraine.

Authors:  Robin James Storer; Weera Supronsinchai; Anan Srikiatkhachorn
Journal:  Curr Pain Headache Rep       Date:  2015-01

2.  Visuospatial learning is fostered in migraine: evidence by a neuropsychological study.

Authors:  Roberta Baschi; R Monastero; G Cosentino; V Costa; G Giglia; B Fierro; F Brighina
Journal:  Neurol Sci       Date:  2019-06-27       Impact factor: 3.307

Review 3.  Glutamate receptor antagonists in the management of migraine.

Authors:  Kayi Chan; Antoinette MaassenVanDenBrink
Journal:  Drugs       Date:  2014-07       Impact factor: 9.546

4.  Intravenous ketamine for subacute treatment of refractory chronic migraine: a case series.

Authors:  Clinton Lauritsen; Santiago Mazuera; Richard B Lipton; Sait Ashina
Journal:  J Headache Pain       Date:  2016-11-22       Impact factor: 7.277

Review 5.  How Well Do Current Laboratory Biomarkers Inform Clinical Decision-Making in Chronic Pain Management?

Authors:  Jonathan M Hagedorn; Joshua Gunn; Ryan Budwany; Ryan S D'Souza; Krishnan Chakravarthy; Timothy R Deer
Journal:  J Pain Res       Date:  2021-12-03       Impact factor: 3.133

6.  Studies on the Mechanism of Glutamate Metabolism in NTG-Induced Migraine Rats Treated with DCXF.

Authors:  Ni Ni; Qingqing Wang; Xiao Lin; Yanlong Hong; Yi Feng; Lan Shen
Journal:  Evid Based Complement Alternat Med       Date:  2019-12-31       Impact factor: 2.629
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.